• 24/03/2022

    TREATS releases final report

    The TREATS (Tuberculosis Reduction through Expanded Antiretroviral Treatment and Screening for Active TB) project has just released its…

    Lees meer
  • 24/03/2022

    IMPAACT4TB raises awareness and access to TB Preventative Treatment

    About a quarter of the world’s population is infected with Mycobacterium Tuberculosis and thus at risk of developing tuberculosis (TB)…

    Lees meer
  • 24/03/2022

    KardiaMobile for ECG monitoring: Innovative approach to help DR-TB patients in Kazakhstan

    KNCV is constantly looking for innovative approaches for patient-centered care. Patients with drug resistant tuberculosis (DR-TB) who receive treatment with…

    Lees meer
  • 04/03/2022

    Save the date: Wolfheze Workshops 2022

    Regaining lost ground: ending TB in Europe 16th WHO National TB Programme Managers’ Meeting and 20th Wolfheze Workshops…

    Lees meer
  • 28/02/2022

    New platform on digital adherence technologies for tuberculosis treatment

    As a part of the Global digital adherence technology (DAT) Task Force, KNCV Tuberculosis Foundation is pleased to announce the…

    Lees meer
  • 21/02/2022

    Dr. Bakyt Myrzaliev receives ‘Award for Partnership to End TB’

    Dr. Bakyt Myrzaliev, KNCV representative in Kyrgyzstan, has been awarded the ‘Award for Partnership to End TB’ by the…

    Lees meer
  • 24/01/2022

    Our sincere condolences for the passing of Dr. Lucie Blok

    The world of public health has lost a great colleague with a passion for teaching and quality public health response,…

    Lees meer
  • 24/01/2022

    Rest in peace, Dr. Baba Awe

    TB Program Nigeria, Afrika and the world will greatly miss the dedicated and passionate Dr. Baba Awe. He has spent…

    Lees meer
  • 21/01/2022

    Success for AMR Global with ‘GLORIA’

    AMR-Global has successfully secured co-funding from the PPP Allowance made available by Health~Holland, Top Sector Life Sciences & Health,…

    Lees meer
  • 10/12/2021

    Optimized models of care for TB prevention among migrants

    On Tuesday, 7 December 2021, the symposium “TB prevention among high-risk migrants in low-burden countries” was held online. The symposium…

    Lees meer
  • 20/11/2021

    On World Children’s Day, KNCV celebrates improved access to diagnosis of TB in children

    Today, on World Children’s Day, we welcome the updated guidance published by the…

    Lees meer
  • 12/11/2021

    KNCV Nigeria awarded at the National TB Conference

    At the National TB Conference in Nigeria, organized by the Stop TB Partnership Nigeria and National TB and…

    Lees meer
  • 08/11/2021

    Calling on the Global Fund to urgently increase allocations for TB

    Today KNCV Tuberculosis Foundation jointly with 57 tuberculosis (TB) civil society and community organizations ask the Board of the…

    Lees meer
  • 03/11/2021

    Establishing a global market for digital adherence technologies

    As part of the ASCENT project, funded by Unitaid,…

    Lees meer
  • 25/10/2021

    Vietnam leads the way with SOS Stool Method to diagnose TB

    Vietnam is the first country in the world to routinely use an innovative method to diagnose tuberculosis (TB) using stool.

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi


De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.